TCAR Definition in Carotid Stenting
TCAR stands for TransCarotid Artery Revascularization, a minimally invasive hybrid technique for treating carotid artery stenosis that uses direct common carotid artery access combined with dynamic flow reversal technology 1.
What TCAR Is
TCAR is a carotid stenting procedure that entirely bypasses the aortic arch by accessing the carotid artery directly through a small incision in the neck 1. The defining feature is the use of "dynamic flow reversal"—blood flow is temporarily reversed during the procedure to redirect any embolic debris away from the brain and into the femoral vein, thereby minimizing stroke risk during stent placement 1.
Key Technical Characteristics
The procedure involves:
- Direct surgical access to the common carotid artery (not percutaneous puncture as in traditional transfemoral CAS)
- Flow reversal system that serves as the primary mechanism of procedural stroke reduction 1
- Avoidance of aortic arch manipulation, eliminating cerebral embolism from arch cannulation 1
- Typically completed in less than 1 hour of operative time 2
Clinical Context and Position
TCAR emerged as an alternative to both carotid endarterectomy (CEA) and transfemoral carotid artery stenting (tfCAS) 3. According to the 2025 ESC consensus statement, TCAR has gained particular popularity in the USA since its commercial introduction in 2015 1, 4.
Current Evidence Status
The 2025 ESC guidelines note that lack of prospective randomized evidence with independent neurological assessments currently precludes routine recommendation for TCAR over CEA in symptomatic patients 1. However, registry data from the VQI TCAR Surveillance Project suggest TCAR may be associated with lower stroke/death risk compared to 1st generation stent tfCAS and similar rates to CEA 1.
Specific Indications Where TCAR Shows Promise
TCAR has potential as preferred treatment in higher-risk patients with specific clinical or anatomic factors 1:
- High carotid lesions (extending cranially to C2 vertebra)
- Cervical spine immobility
- Post-CEA restenosis
- Prior neck irradiation
- "Hostile neck" anatomy
- Severe aortic or femoral artery pathology 1
Important Anatomical Requirements
TCAR has specific anatomical prerequisites that limit its universal applicability 1:
- Disease-free common carotid artery at the puncture site
- ≥5 cm distance between clavicle and carotid bifurcation
- Minimal to no atherosclerosis at the common carotid artery access point 1
Comparative Outcomes
Recent meta-analysis data (2026) demonstrate that TCAR is associated with 5:
- Significantly reduced 30-day mortality (RR 0.45; P < 0.001)
- Lower 30-day stroke rates (RR 0.66; P < 0.001)
- Reduced composite stroke/death (RR 0.57; P < 0.001)
- Lower TIA rates compared to tfCAS
However, a 2025 propensity-matched analysis found that with 1st generation stents, symptomatic patients had similar 1-year ipsilateral stroke or death between TCAR and tfCAS (HR 0.99; 95% CI 0.74–1.32) 1.
Current Limitations
Important caveats include 1:
- Most TCAR data comes from registries, not randomized trials
- Patient populations in TCAR studies may differ from CEA/tfCAS studies
- European real-world data (340 patients) failed to confirm advantages of transcervical approach 1
- TCAR is viewed in Europe as promising but requiring RCT validation before recommending as CEA alternative 1
The technique represents an evolving option in the carotid revascularization armamentarium, with ongoing need for robust comparative trials 1, 3.